Global TB Programme
Diana E.C. Weil, Coordinator, Policy and Strategy
Diana Weil has twenty years of experience in global public health policy analysis, program support, and disease control strategy development. She joined WHO in 1991, first at headquarters and then worked at the WHO Regional Office of the Americas/Pan American Health Organization, and on secondment at the World Bank. She has collaborated with ministries of health in Latin America, Asia and Africa, and has conducted analyses on the impact of development policies on health, the impact of health system reforms on disease control, the role for incentives and enablers in service delivery, international financing for TB control, and anti-TB drug supply systems and markets.
Ms Weil has served on numerous interagency panels and committees to devise innovative solutions in drug supply, health systems delivery and financing, and TB care and control. She has participated in the development of tools to support implementation of the DOTS Strategy, in the formulation of the Stop TB Strategy, the Global Drug Facility and the Stop TB Partnership's two global plans. She holds degrees from Brown University and the Harvard School of Public Health. Previous to joining WHO, she was Research Associate and Assistant Director of the Takemi Program in International Health, Harvard School of Public Health.